![SK bioscience Co.,Ltd. logo](/logos/302440.KS.webp)
SK bioscience Co.,Ltd.
KRX:302440.KS
Overview | Financials
Company Name | SK bioscience Co.,Ltd. |
Symbol | 302440.KS |
Currency | KRW |
Price | 51,800 |
Market Cap | 3,979,674,860,000 |
Dividend Yield | 0% |
52-week-range | 48,600 - 74,000 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Jae-Yong Ahn |
Website | https://www.skbioscience.co.kr |
An error occurred while fetching data.
About SK bioscience Co.,Ltd.
SK bioscience Co.,Ltd. engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally. Its product portfolio includes Skycellflu, a cell cultured influenza surface antigen vaccine; Skycellflu 4-ga pre-filled syringe; pneumococcal vaccine for adult and infant; Skyzoster, a shingles virus vaccine; and Sky Baricella
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD